Oncomed pharmaceuticals inc (OMED)
Balance Sheet / Yearly
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Dec'12
Assets
Current assets:
Cash

-

-

-

-

-

-

-

39,195

-

-

-

-

38,444

-

-

-

-

-

-

-

-

-

-

-

Cash and cash equivalents

9,686

8,406

10,561

14,125

13,277

15,877

31,940

-

36,953

30,084

37,771

84,563

-

31,280

36,255

29,115

28,138

29,995

23,379

25,950

208,931

11,092

16,173

16,263

Short-term investments

47,659

62,450

69,305

74,299

89,814

97,710

97,828

117,740

147,620

177,506

133,756

108,940

118,835

143,925

163,973

183,933

203,828

217,878

242,969

257,963

107,263

117,554

40,291

49,976

Accounts receivable and other receivables

3,026

416

110

258

405

348

1,990

1,652

2,515

2,248

2,021

1,308

70,699

315

-

-

42

-

-

-

-

-

-

-

Receivables-related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

15

-

0

-

-

23

-

-

-

Accounts receivable - collaboration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,000

-

-

Receivables - related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

23

-

23

23

4,023

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,072

48

-

0

-

-

-

Tax receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,102

7,102

2,562

-

-

0

-

-

-

Prepaid and other current assets

1,913

1,913

1,493

1,669

1,709

2,430

3,220

3,203

2,495

2,836

2,534

3,565

3,277

1,785

1,162

1,799

1,700

3,573

2,784

2,502

2,527

1,929

1,224

1,123

Assets held for sale

1,443

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

63,727

73,185

81,469

90,351

105,205

116,365

134,978

161,790

189,583

212,674

176,082

198,376

231,255

177,305

201,399

221,964

240,810

256,080

269,203

286,438

318,744

140,598

57,711

71,385

Property and equipment, net

623

2,362

2,532

2,934

3,275

3,368

3,783

4,172

4,471

4,355

4,643

4,907

4,825

5,065

5,349

5,119

5,104

4,965

5,168

4,962

4,641

4,569

4,884

5,462

Other assets

728

1,606

1,908

1,846

1,842

748

584

984

1,428

1,159

1,168

1,647

1,807

2,204

2,333

1,925

1,928

7,895

9,933

10,486

10,300

43

3,639

2,921

Total assets

65,078

77,153

85,909

95,131

110,322

120,481

139,345

166,946

195,482

218,188

181,893

204,930

237,887

184,574

209,081

229,008

247,842

268,940

284,304

301,886

333,685

145,210

66,234

79,768

Liabilities and stockholders' deficit
Current liabilities:
Accounts payable

1,787

3,163

981

704

2,565

779

2,115

3,910

4,890

5,436

4,451

3,212

6,660

3,441

6,143

3,073

4,448

3,795

3,033

2,935

5,706

2,101

812

849

Income tax payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

10,758

-

-

-

Accrued liabilities

4,368

4,571

3,762

2,956

3,940

4,634

5,136

6,660

8,599

8,732

9,263

9,429

11,475

18,424

13,955

13,092

7,834

15,197

12,062

10,064

9,860

6,865

6,008

3,798

Accrued clinical liabilities

2,736

2,327

2,575

3,286

4,434

8,880

12,558

18,708

21,854

19,731

18,799

13,649

12,221

-

-

-

6,829

-

-

-

-

-

-

-

Current portion of deferred revenue

3,697

11,278

25,908

-

82,193

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred revenue

-

-

-

27,919

-

20,053

20,053

20,192

20,510

20,799

21,058

21,393

21,543

15,102

16,525

17,636

18,747

21,186

34,625

35,059

35,059

22,726

22,726

14,726

Current portion of deferred rent

56

-

-

-

-

-

-

-

-

783

768

753

738

723

708

693

678

665

651

637

624

610

596

560

Liability for shares issued with repurchase rights

-

-

-

-

-

-

-

-

-

-

-

2

4

7

9

10

10

10

-

-

10

-

-

-

Liability for shares issued with repurchase rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

10

-

10

11

14

Convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

328

182

Total current liabilities

12,644

21,339

33,226

34,865

93,132

34,346

39,862

49,470

55,853

55,481

54,339

48,438

52,641

37,697

37,340

34,504

38,546

40,853

50,381

48,705

62,017

32,312

30,481

20,129

Deferred revenue, less current portion

-

-

4,888

-

61,645

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, less current portion

-

-

-

9,748

-

144,333

149,347

154,360

159,373

164,387

169,400

174,413

179,612

119,708

122,972

126,547

130,123

133,699

137,275

142,856

148,871

8,525

11,457

17,320

Deferred rent, less current potion

4,103

4,090

3,820

3,800

3,765

3,579

3,548

3,517

2,917

1,132

1,333

1,534

1,729

1,915

2,101

2,287

2,468

2,638

2,809

2,980

3,146

3,303

3,460

3,750

Noncurrent income tax payable

-

-

-

386

383

378

375

371

367

369

360

356

354

369

357

345

334

2,321

1,528

1,517

1,515

-

-

-

Other liabilities

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability for shares issued with repurchase rights, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

4

6

-

-

14

-

-

-

Liability for shares issued with repurchase rights, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

11

-

16

18

23

Total liabilities

16,847

25,429

41,934

48,799

158,925

182,636

193,132

207,718

218,510

221,369

225,432

224,741

234,336

159,689

162,770

163,685

171,475

179,517

192,001

196,069

215,563

44,156

45,416

41,222

Commitments and contingencies (Note 7)

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity (deficit):
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2018 and 2017; no shares issued and outstanding at December 31, 2018 and 2017

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

182,773

0

Common stock, $0.001 par value; 145,000,000 shares authorized at December 31, 2018 and 2017; 38,660,146 and 38,212,505 shares issued and outstanding at December 31, 2018 and 2017, respectively

38

38

38

38

38

38

37

37

37

37

30

30

30

30

30

30

30

30

30

30

29

28

-

6

Additional paid-in capital

410,008

408,868

407,229

405,397

403,077

399,102

396,683

394,476

389,620

387,201

321,014

317,080

313,344

309,796

306,762

304,183

300,790

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

298,739

296,178

294,113

292,505

271,091

4,621

4,107

Accumulated other comprehensive (loss) income

-29

-62

-57

156

289

175

272

268

260

191

162

135

20

124

104

75

-17

34

-11

-29

14

17

15

15

Accumulated deficit

-361,786

-357,120

-363,235

-359,259

-452,007

-461,470

-450,779

-435,553

-412,945

-390,610

-364,745

-337,056

-309,843

-285,065

-260,585

-238,965

-224,436

-209,380

-203,894

-188,297

-174,426

-170,082

-166,597

-148,355

Total stockholders’ equity (deficit)

48,231

51,724

43,975

46,332

-48,603

-62,155

-53,787

-40,772

-23,028

-3,181

-43,539

-19,811

3,551

24,885

46,311

65,323

76,367

89,423

92,303

105,817

118,122

101,054

-161,955

-144,227

Total liabilities and stockholders’ equity (deficit)

65,078

77,153

85,909

95,131

110,322

120,481

139,345

166,946

195,482

218,188

181,893

204,930

237,887

184,574

209,081

229,008

247,842

268,940

284,304

301,886

333,685

145,210

66,234

79,768